These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36759786)

  • 21. Nanoparticle-based immunotherapy of breast cancer using recombinant Helicobacter pylori proteins.
    Mohabati Mobarez A; Soleimani N; Esmaeili SA; Farhangi B
    Eur J Pharm Biopharm; 2020 Oct; 155():69-76. PubMed ID: 32798667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CD44v
    Hu J; Li G; Zhang P; Zhuang X; Hu G
    Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity.
    Lugade AA; Bharali DJ; Pradhan V; Elkin G; Mousa SA; Thanavala Y
    Nanomedicine; 2013 Oct; 9(7):923-34. PubMed ID: 23542018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant flagellin-PAL fusion protein of Legionella pneumophila induced cell-mediated and protective immunity against bacteremia in BALB/c mice.
    Mohabati Mobarez A; Ahmadrajabi R; Khoramabadi N; Salmanian AH
    World J Microbiol Biotechnol; 2017 Sep; 33(9):175. PubMed ID: 28887725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.
    Chehelgerdi M; Doosti A
    J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of immunological responses to recombinant Porin A protein (rPoA) from native strains of Neisseria meningitidis serogroups A and B using OMV as an adjuvant in BALB/c mice.
    Afrough P; Bouzari S; Mousavi SF; Asadi Karam MR; Vaziri F; Fateh A; Behrouzi A; Malekan M; Siadat SD
    Microb Pathog; 2017 Nov; 112():209-214. PubMed ID: 28942175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice.
    Wen ZS; Xu YL; Zou XT; Xu ZR
    Mar Drugs; 2011; 9(6):1038-1055. PubMed ID: 21747747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E. coli O157: H7.
    Hajizade A; Salmanian AH; Amani J; Ebrahimi F; Arpanaei A
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1067-S1075. PubMed ID: 30638077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice.
    Danesh-Bahreini MA; Shokri J; Samiei A; Kamali-Sarvestani E; Barzegar-Jalali M; Mohammadi-Samani S
    Int J Nanomedicine; 2011; 6():835-42. PubMed ID: 21589651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of a chitosan-based nano vaccine against epsilon toxin of
    Poorhassan F; Nemati F; Saffarian P; Mirhosseini SA; Motamedi MJ
    Res Pharm Sci; 2021 Dec; 16(6):575-585. PubMed ID: 34760006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral immunization of mice with Omp31-loaded
    Abkar M; Fasihi-Ramandi M; Kooshki H; Sahebghadam Lotfi A
    Int J Nanomedicine; 2017; 12():8769-8778. PubMed ID: 29263667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of recombinant vaccine candidate molecule against Shigella infection.
    Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
    Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a chitosan-modified PLGA nanoparticle vaccine for protection against Escherichia coli K1 caused meningitis in mice.
    Zhang J; Sun H; Gao C; Wang Y; Cheng X; Yang Y; Gou Q; Lei L; Chen Y; Wang X; Zou Q; Gu J
    J Nanobiotechnology; 2021 Mar; 19(1):69. PubMed ID: 33673858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan Nanoparticles Loaded with Truncated ORF2 Protein as an Oral Vaccine Candidate against Hepatitis E.
    Wei W; Behloul N; Wang W; Baha S; Liu Z; Shi R; Meng J
    Macromol Biosci; 2021 Apr; 21(4):e2000375. PubMed ID: 33624916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
    Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
    J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule.
    Silvestre BT; Rabelo ÉM; Versiani AF; da Fonseca FG; Silveira JA; Bueno LL; Fujiwara RT; Ribeiro MF
    Vaccine; 2014 Apr; 32(19):2160-6. PubMed ID: 24606864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer.
    Sheikhzadeh S; Delirezh N; Hobbenaghi R
    Biomed Pharmacother; 2021 Oct; 142():111962. PubMed ID: 34358752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of BLF1-containing trimethyl chitosan nanoparticles and evaluation of its immunogenicity and protection in syrian mice by oral and subcutaneous injections.
    Fazeli A; Honari H; Sadeghi D; Bakhtiari H
    Protein Expr Purif; 2024 Jul; 219():106462. PubMed ID: 38556142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
    Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.